Pictet Asset Management (Switzerland)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-248,045
| Closed | -$2.62M | – | 1995 |
|
|
2023
Q1 | $2.62M | Buy |
248,045
+170,987
| +222% | +$1.8M | ﹤0.01% | 885 |
|
|
2022
Q4 | $2.61M | Buy |
77,058
+19,710
| +34% | +$668K | ﹤0.01% | 877 |
|
|
2022
Q3 | $2.75M | Buy |
57,348
+34,398
| +150% | +$1.65M | ﹤0.01% | 853 |
|
|
2022
Q2 | $1.31M | Buy |
22,950
+22,032
| +2,400% | +$1.26M | ﹤0.01% | 1001 |
|
|
2022
Q1 | $74K | Hold |
918
| – | – | ﹤0.01% | 1628 |
|
|
2021
Q4 | $186K | Hold |
918
| – | – | ﹤0.01% | 1606 |
|
|
2021
Q3 | $247K | Buy |
+918
| New | +$247K | ﹤0.01% | 1498 |
|